Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation
ConclusionsIn patients greater than 50 years, the FRAX tool has modest predictive ability and could be used to aid in preventive treatment decision-making at the time of transplant.
Source: Archives of Orthopaedic and Trauma Surgery - Category: Orthopaedics Source Type: research
More News: Cancer | Cancer & Oncology | Orthopaedics | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants